| Literature DB >> 36230049 |
Sumei Hu1, Caiyu Liu1, Xinqi Liu1.
Abstract
Metabolomics, as a new omics technology, has been widely accepted by researchers and has shown great potential in the field of nutrition and health in recent years. This review briefly introduces the process of metabolomics analysis, including sample preparation and extraction, derivatization, separation and detection, and data processing. This paper focuses on the application of metabolomics in food-derived bioactive ingredients. For example, metabolomics techniques are used to analyze metabolites in food to find bioactive substances or new metabolites in food materials. Moreover, bioactive substances have been tested in vitro and in vivo, as well as in humans, to investigate the changes of metabolites and the underlying metabolic pathways, among which metabolomics is used to find potential biomarkers and targets. Metabolomics provides a new approach for the prevention and regulation of chronic diseases and the study of the underlying mechanisms. It also provides strong support for the development of functional food or drugs. Although metabolomics has some limitations such as low sensitivity, poor repeatability, and limited detection range, it is developing rapidly in general, and also in the field of nutrition and health. At the end of this paper, we put forward our own insights on the development prospects of metabolomics in the application of bioactive ingredients in food.Entities:
Keywords: food-derived bioactive ingredients; functional food; metabolites; metabolomics
Year: 2022 PMID: 36230049 PMCID: PMC9562173 DOI: 10.3390/foods11192974
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Numbers of publications using NMR, LC-MS, and GC-MS over the years for metabolomics analysis in the last decade by searching PubMed database with the keywords of metabolomics and NMR/LC-MS/GC-MS.
Figure 2The process of metabolomics analysis. (Some picture elements are from the BioRender).
Metabolomics applications in food-derived bioactive ingredients.
| Main | Sample | Analytical | Application of Metabolomics | Reference |
|---|---|---|---|---|
| Flavonoids | Soybean seeds | LC-ESI-MS/MS | Evaluated the dynamic changes of metabolites in soybean seeds before and after germination. | [ |
| Amino acids, | Mung bean | NMR | Evaluated the dynamic changes of metabolites in mung bean at different germination stages. | [ |
| Flavonoids and polyphenols | Green tea bud | UPLC-QTOF-MS | Combined the characteristic metabolites with in vitro biological activities to determine the health effects of natural metabolites. | [ |
| Isoflavones and alkaloids | 1H NMR | Identified the effects of different extract components on the bioactivities of metabolites. | [ | |
| Procyanidin C1, orientin, | Hawthorn | UHPLC-Q-TOF/MS | Screened the metabolites with specific biological activities by combining various types of stoichiometry. | [ |
| Polyphenols, | Four | UHPLC-QTOF | Compared the changes of metabolite concentrations before and after simulated gastrointestinal digestion in vitro. | [ |
| Polyphenol | Red beet and amaranth | UHPLC-QTOF | Identified the effects of different storage periods on metabolite changes. | [ |
| Phenyllactate and ferulate | Soybean | UHPLC/MS/MS2 | Analyzed the compounds with significant effects on cell growth and IgG production. | [ |
| Ornithine and | Soybean | LC-MS/MS | Screened productivity markers by comparing cell growth condition. | [ |
| Phenolic | Red kidney bean extracts | NMR | Analyzed the antiproliferative mechanism of different chemical components on B16-F10 melanoma cells. | [ |
| Alanine, aspartate and glutamate | CG | UPLC-MS/MS | Studied the effects of different concentrations of CG on L-02 cells metabolism. | [ |
| Glutamate and lactate | Exendin-4 | NMR | Investigated the mechanism of protective effect of exendin-4 on mouse glomerulus mesangial cells. | [ |
| Glycerolipid, cyanomino acid, inositol phosphate, etc. | Vitamin C | 1H NMR | Determined the effect of half inhibitory concentration of Vitamin C on cell metabolism. | [ |
| Alanine, | Emodin | 1H NMR | Evaluated the cytotoxic effects of high concentrations of emodin on cells. | [ |
| Lactate and | Doxorubicin and dexrazoxane | 1H NMR | Identified the important factor of dextroprazole induced cardiotoxicity. | [ |
| Nicotinamide, nicotinic acid, | Quinoa saponins | UHPLC-MS | Combined the metabolomics with the changes of intestinal microbes in rats and identified the differential effects of quinoa saponins on different sexes. | [ |
| Phosphatidylcholine and | Corn silk | UPLC-ESI-Q-TOF/MS | Identified the changes of diabetes markers through the differences of serum metabolites in rats. | [ |
| Flavonoids | Fenugreek | UPLC-Q-TOF-MS | Investigated the function of fenugreek flavonoids in regulating blood glucose by serum metabolomics. | [ |
| Valine, leucine, LPCs, etc. | RS3 | UHPLC-LTQ/Orbitrap MS | Identified the antidiabetic mechanism of RS3 by urine metabolomics. | [ |
| Alanine, | GAP | LC-MS | Studied the regulation of GAP on mice with nonalcoholic fatty liver by serum metabolomics. | [ |
| Phenylalanine, | EP | LC-MS | Combined the metabolomics with molecular docking technology to obtain effective bioactive components. | [ |
| Arginine and | The hydrolysates of yak bone glue | UPLC-QTF/MS | Determined the anti-obesity mechanism of the hydrolysates of yak bone glue by fecal metabolomics. | [ |
| Propionic acid, taurine, | Astaxanthin | LC-MS | Clarified the mechanism of astaxanthin alleviating oxidative stress in rats. | [ |
| Galactose, galactonate and lactic | Cheese, milk and soy beverages | GC-MS | Explored possible food biomarkers of human intake by metabolomics. | [ |
| 5-(dihydroxyphenyl)-γ-valerolactones and 4-hydroxyl-5-(phenyl)-valeric acids | Red wine | UHPLC−TOF-MS | Determined the health effects of moderate red wine consumption on human metabolism by urine metabolomics and fecal metabolomics. | [ |
| Lysophosphatidylcholines, lysophosphatidylethanolamines and | Garlic supplements | HPLC-ESI-QTOF-MS | Verified the function of garlic supplement in enhancing immunity by fingerprint metabolomics. | [ |
| 3,8-dihydroxy-urolithin derivatives and | A (poly) phenols-rich test drink | UHPLC-QQQ | Determined the regulating mechanism of polyphenol beverage on diabetes patients by blood and urine metabolomics. | [ |
| Choline | ECa 233 | 1H NMR | Evaluated the drug bioavailability of ECa 233 by metabolomics. | [ |